Scorpius Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!About SCPX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees84
Employees84
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded2008
Founded2008
Employees84
Employees84
SCPX Key Statistics
Market cap396.35
Market cap396.35
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume13.08K
Average volume13.08K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$146.00
52 Week high$146.00
52 Week low$1.35
52 Week low$1.35
Stock Snapshot
As of today, Scorpius Holdings(SCPX) shares are valued at $0.00. The company's market cap stands at 396.35, with a P/E ratio of -0.02.
Scorpius Holdings(SCPX) stock opened on 2026-07-13 at —. The price climbed to — and dipped to —.
The Scorpius Holdings(SCPX)'s current trading volume is 0, compared to an average daily volume of 13.08K.
In the last year, Scorpius Holdings(SCPX) shares hit a 52-week high of $146.00 and a 52-week low of $1.35.
In the last year, Scorpius Holdings(SCPX) shares hit a 52-week high of $146.00 and a 52-week low of $1.35.
People also own
Based on the portfolios of people who own SCPX. This list is generated using Robinhood data, and it’s not a recommendation.